In cases of chronic lymphocytic leukemia (CLL), blocking the signaling pathway of the colony-stimulating factor 1 receptor (CSF1R) or using clodronate liposomes to kill macrophages can effectively hinder the growth of the leukemia (68). Here, CSF1R is linked to B-cell chronic lymphocytic leukemia.